sur MTS US
Innovative Breakthroughs in Aesthetic Medicine: Dr. Maria Fedchuk’s Contributions
The 22nd Aesthetic & Anti-Aging Medicine World Congress in Monaco showcased a major innovation in beauty and health. Dr. Maria Fedchuk introduced the "EXOSOMAL LIQUID LASER," an advanced treatment protocol she developed through extensive clinical trials.
At the same event, Dermoaroma's RADIANCE from the PEELING SYSTEM received the "Aesthetic Medicine Award." Dr. Fedchuk's scientific expertise supported this achievement. With FDA approval, these technologies are now available in the U.S. through MTS US.
Dr. Fedchuk, a fourth-generation physician from Ukraine, co-founded MTS US. She has led advancements in aesthetic medicine, including the use of non-human exosomes and secretomes.
Her 18 years in the field, combined with her role as a scientific advisor and trainer, position her as a global leader in aesthetic medicine. Her work emphasizes patient safety and innovation, particularly in regenerative and anti-aging treatments.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de MTS US